Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Jun 2023. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 11778211000202117 | Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 11793881000202112 | Clindamycin (as clindamycin phosphate) 10 mg/g and tretinoin 250 microgram/g cutaneous gel | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug) | Is a | Product containing only clindamycin and tretinoin in cutaneous dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has manufactured dose form | Cutaneous gel | true | Inferred relationship | Some | ||
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug) | Plays role | Antibacterial therapeutic role (role) | false | Inferred relationship | Some | ||
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has precise active ingredient | Clindamycin phosphate | true | Inferred relationship | Some | 1 | |
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has basis of strength substance (attribute) | Clindamycin (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 1 | |
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has precise active ingredient | Tretinoin (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has basis of strength substance (attribute) | Tretinoin (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength numerator unit | mcg | true | Inferred relationship | Some | 2 | |
| Product containing precisely clindamycin (as clindamycin phosphate) 10 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
FHIR